ESC 365 - XPO1 gene silencing in heart failure. A new therapeutic strategy

ESC Premium Access

XPO1 gene silencing in heart failure. A new therapeutic strategy

Session: Poster session 2 - Cardiac genetics and ageing

Topic: Genetics and gene therapy

Speaker: Doctor E. Rosello-Lleti (Valencia, ES)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Doctor Esther Rosello-Lleti

Health Research Institute La Fe, Valencia (Spain)

1 follower

14 more presentations in this session

Aberrant glycosylation patterns of human arrhythmogenic cardiomyopathy-associated Desmoglein-2 sequence variants

Speaker: Miss J. Debus (Bad Oeynhausen, DE)

Effect of angiotensin-converting enzyme gene polymorphisms on cardiovascular and renal clinical outcomes in patients with coronary artery disease: 10-years follow-up results

Association of a polymorphism of the butyrophilin, subfamily 2, member A1 gene with hypertension in community-dwelling Japanese individuals

Speaker: Doctor Y. Yamase (Tajimi, JP)

Endothelium-dependent vasodilation in patients with neuropathic and neuroischemic forms of diabetic foot syndrome in the treatment methods of cell and gene therapy

Speaker: Assistant Professor A. Kotslova (Saint Petersburg, RU)

Additive effects of multiple genetic variants on the risk of coronary artery disease

Speaker: Professor A. Pereira (Funchal, PT)

Access the full session

Poster session 2 - Cardiac genetics and ageing

Speakers: Doctor E. Rosello-Lleti, Miss J. Debus, Doctor Y. Yamase, Assistant Professor A. Kotslova, Professor A. Pereira

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources